What is the primary indication for Albuterol?

Albuterol is primarily indicated for relieving bronchospasm, which makes it a key medication in the management of conditions such as asthma and chronic obstructive pulmonary disease (COPD). As a bronchodilator, it works by relaxing the muscles in the airways, leading to widened air passages and improved airflow. This action is crucial for patients experiencing difficulty breathing due to constricted airways.

The other options pertain to different therapeutic goals. Reducing fever is generally achieved with antipyretics, treating bacterial infections requires antibiotics, and enhancing cardiac output is managed with cardiovascular medications rather than bronchodilators like Albuterol. Therefore, the specific and focused action of Albuterol in easing bronchospasm is what distinctly identifies it for this particular use.